Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 1Sarcoma 1Head & Neck 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 59Small Cell Lung Carcinoma 13Lung Neoplasms 13Colorectal Neoplasms 6Sarcoma 5Neoplasm Metastasis 5Melanoma 5Adenocarcinoma of Lung 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3NSCLC 3Carcinoma, Renal Cell 3Uterine Cervical Neoplasms 2Mesothelioma 2Extensive Stage Small Cell Lung Cancer 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Uveal Melanoma 1Unresectable Stage III Non-small Cell Lung Cancer 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Testicular Germ Cell Tumor 1Small Cell Lung Cancer Extensive Stage 1SCLC, Extensive Stage 1Radiation Pneumonitis 1Perioperative Immunotherapy 1Pancreatic Neoplasms 1Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder) 1Non Squamous Non-small Cell Lung Cancer 1

Interventions

pembrolizumab 39Gemcitabine 30Nivolumab 15Cetuximab 13Carboplatin 13Cyclophosphamide 12Cisplatin 12Irinotecan 10Docetaxel 10130-nm albumin-bound paclitaxel 10Trastuzumab 8Magnetic Resonance Spectroscopy 8fludarabine 7aldesleukin 7Paclitaxel 7Drug Therapy 7Bevacizumab 7Taxes 6Specimen Handling 6Fluorouracil 6Capecitabine 6Albumin-Bound Paclitaxel 6sargramostim 5Pemetrexed 5Oxaliplatin 5Ipilimumab 5spartalizumab 4durvalumab 4Standard of Care 4Radiotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × tislelizumab × Thoracic × Clear all
NCT06332274 2025-05-13

UMBRELLA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
717 enrolled
GastrointestinalSarcomaThoracic

Colonic Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡